#cervical cancer — Tuesday, August 04, 2026 (1 items)
| 0 | 💬 0 |
Iparomlimab and tuvonralimab in previously treated patients with cervical cancer.
(linkinghub.elsevier.com)
|
Cell Reports Medicine 2026-08-04 | #clinical trial #immunotherapy #cervical cancer #oncology #checkpoint-inhibitors |